Abstract
Division of Hematology Oncology Massachusetts General Hospital Boston, Massachusetts Financial disclosure/conflicts of interest: R.T.P. has served in the scientific advisory boards of Genentech Inc., AstraZeneca, Lifecore Biomedical, Biomarin Pharmaceuticals Inc., Clovis Oncology, and Seattle Genetics, and has received research funding from ImClone Systems Inc., Endocyte Inc., AstraZeneca, Eisai Inc., and Amgen Inc.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
